Skip to content

BBNX BBNX Cash ratio

Cash ratio at other companies

Insulet logo
InsuletPODD
0.7×-1.8×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
0.7×+0.5×
Medtronic logo
MedtronicMDT
0.2×0.0×
AdaptHealth logo
AdaptHealthAHCO
0.1×0.0×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
0.9×-0.3×

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Calculated from BBNX’s reported figures.

Based on the most recent quarter.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's cash ratio?
BBNX (BBNX) reported cash ratio of 1.3× in Q1 2026.
How has BBNX's cash ratio changed year-over-year?
BBNX's cash ratio decreased by 49.4% year-over-year, from 2.6× to 1.3×.
What is the long-term trend for BBNX's cash ratio?
Over 2 years (2023 to 2025), BBNX's cash ratio has grown at a -36.2% compound annual growth rate (CAGR), from 2.5× to 1×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.